2022 Recipient is DNDi
For 2022, we have chosen Drugs for Neglected Diseases initiative (DNDi). In 2003, MSF, the World Health Organization, and five international research institutions founded the Drugs for Neglected Diseases initiative (DNDi). They discover, develop, and deliver new treatments for neglected patients around the world that are affordable and patient-friendly – and have already saved millions of lives. DNDi’s focus stood out to us at Arbor Assays, and we’re thrilled to support them this year.
Announcing our 2021 Research the Cure Recipient – Brain Chemistry Labs
“…We care only for patients, not profits.” – Brain Chemistry Labs
ARBOR ASSAYS’ RESEARCH THE CURE™ PROGRAM
At Arbor Assays, we believe we should be proactive in giving back to the community. We are offering our Research The Cure™ program for the 10th consecutive year. This program helps support important medical research with a portion of proceeds from every purchase going directly to a chosen charity.
Each year, we donate to a different charity. If you have a recommendation for future Research the Cure™ beneficiaries, click here to send us your suggestion!